All Stories

  1. The neurologist of 2050: Rethinking the role in movement disorders in a technologically transformed society

    Article • Neurological Sciences, August 2026, Springer Science + Business Media

    Carlo Alberto Artusi

  2. Levodopa-induced dyskinesia is associated with worse gait and balance in Parkinson’s disease

    Article • Acta Neurovegetativa, June 2026, Springer Science + Business Media

    Carlo Alberto Artusi

  3. L-Dopa/Carbidopa intestinal gel infusion in advanced Parkinson’s disease: real-life mobility insights from wearable sensors

    Article • Frontiers in Neurology, June 2026, Frontiers

    Carlo Alberto Artusi

  4. Multicenter validation of the Italian Pain in Dystonia Scale in idiopathic adult-onset cervical dystonia

    Article • Neurological Sciences, May 2026, Springer Science + Business Media

    Carlo Alberto Artusi

  5. From RGB-D to RGB-Only: Reliability and Clinical Relevance of Markerless Skeletal Tracking for Postural Assessment in Parkinson’s Disease

    Article • Sensors, February 2026, MDPI AG

    Carlo Alberto Artusi

  6. Placebo Responses in Trials of Functional Neurologic Disorders

    Article • Neurologic Clinics, February 2026, Elsevier

    Carlo Alberto Artusi

  7. A multi-level annotated sensor dataset of gait freezing manifestations and severity in Parkinson’s disease

    Article • Scientific Data, January 2026, Springer Science + Business Media

    Carlo Alberto Artusi

  8. Unraveling gait and balance impairment in cervical dystonia: associated features, functional implications, and the effect of botulinum toxin

    Article • Parkinsonism & Related Disorders, January 2026, Elsevier

    Carlo Alberto Artusi

  9. Is segmental/multifocal onset a distinct presentation of idiopathic adult-onset dystonia?

    Article • Journal of the Neurological Sciences, January 2026, Elsevier

    Carlo Alberto Artusi

  10. Profiling Postural Instability in Parkinson’s disease: Multi-Parametric Phenotyping and Clinical Correlates from Markerless RGB-D Tracking

    Article • January 2026, Elsevier

    Carlo Alberto Artusi

  11. Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a GBA1 Pathogenic Variant

    Article • Neurology, November 2025, Wolters Kluwer Health

    Carlo Alberto Artusi

  12. Early Detection of Dysphagia Signs in Parkinson’s Disease: An Artificial Intelligence-Based Approach Using Non-Invasive Sensors

    Article • Sensors, November 2025, MDPI AG

    Carlo Alberto Artusi

  13. GBA1 status and sex impact on depression severity and progression in Parkinson’s Disease

    Article • November 2025, Springer Science + Business Media

    Carlo Alberto Artusi

  14. Clinical Algorithm‐Guided Approach to Botulinum Toxin Type A Treatment for Axial Postural Abnormalities in Parkinson's Disease

    Article • Movement Disorders Clinical Practice, November 2025, Wiley

    Dr Christian Geroin, Carlo Alberto Artusi

  15. Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulation

    Article • npj Parkinson s Disease, October 2025, Springer Science + Business Media

    Carlo Alberto Artusi, Professor Fabio Nonino

  16. Predictors of cognitive performance in idiopathic adult-onset dystonia

    Article • Acta Neurovegetativa, October 2025, Springer Science + Business Media

    Carlo Alberto Artusi

  17. The Complex Pathway of Conventional Investigations before the Diagnosis of Functional Motor Disorders

    Article • Movement Disorders Clinical Practice, September 2025, Wiley

    Dr Christian Geroin, Carlo Alberto Artusi

  18. Identifying Poor Responders to STN DBS in Parkinson Disease: The Role of Rapid Disease Progression in the First Year in Optimal Responders to Levodopa

    Article • European Journal of Neurology, September 2025, Wiley

    Carlo Alberto Artusi

  19. Nonmotor fluctuations in Parkinson’s disease: impact on caregiving and quality of life

    Article • Deutsche Zeitschrift für Nervenheilkunde, September 2025, Springer Science + Business Media

    Carlo Alberto Artusi

  20. The Influence of Genetics in the Early Development of Axial Postural Abnormalities in Parkinson's Disease

    Article • Movement Disorders Clinical Practice, August 2025, Wiley

    Carlo Alberto Artusi

  21. Parkinsonism-hyperpyrexia syndrome due to gastroparesis treated with subcutaneous foslevodopa: a case report

    Article • Deutsche Zeitschrift für Nervenheilkunde, August 2025, Springer Science + Business Media

    Carlo Alberto Artusi

  22. The relationship between occupation and specific forms of idiopathic adult-onset dystonia

    Article • Neurological Sciences, June 2025, Springer Science + Business Media

    Carlo Alberto Artusi

  23. Clinical MRI to predict motor and non-motor effects of deep brain stimulation in Parkinson disease

    Article • La radiologia medica, June 2025, Springer Science + Business Media

    Carlo Alberto Artusi

  24. Editorial: Digital biomarkers in movement disorders

    Article • Frontiers in Neurology, May 2025, Frontiers

    Carlo Alberto Artusi

  25. Theta‐Gamma Subthalamic Stimulation for Verbal Fluency in Parkinson's Disease: A Randomized, Crossover Trial

    Article • Movement Disorders, May 2025, Wiley

    Carlo Alberto Artusi

  26. Reply: “Human Pose Estimation Is Approximate: Limitations and Considerations for its Use in Clinical Trials”

    Article • Movement Disorders Clinical Practice, April 2025, Wiley

    Dr Christian Geroin, Carlo Alberto Artusi

  27. Advances in diagnosis, classification, and management of pain in Parkinson's disease

    Article • The Lancet Neurology, April 2025, Elsevier

    Carlo Alberto Artusi

  28. Freezing of gait detection: The effect of sensor type, position, activities, datasets, and machine learning model

    Article • Journal of Parkinson’s Disease, February 2025, SAGE Publications

    Carlo Alberto Artusi

  29. Dynamic Video Assessment of Axial Postural Abnormalities in Parkinson's Disease: A Pilot Study

    Article • Movement Disorders Clinical Practice, January 2025, Wiley

    Dr Christian Geroin, Carlo Alberto Artusi

  30. Siponimod Modulates Functional Brain Connectivity in Patients with Transitional Multiple Sclerosis

    Article • January 2025, Elsevier

    Carlo Alberto Artusi

  31. Long-term motor and cognitive outcome of Deep Brain Stimulation in GBA-PD: the Italian PARKNET study

    Article • December 2024, Cold Spring Harbor Laboratory Press

    Alessio Di Fonzo, Carlo Alberto Artusi

  32. Expanded and independent validation of the NoMoFA scale for Parkinson’s disease: the Italian version

    Article • Deutsche Zeitschrift für Nervenheilkunde, December 2024, Springer Science + Business Media

    Carlo Alberto Artusi

  33. First byte syndrome successfully treated with parotid gland botulinum toxin injection

    Article • Neurological Sciences, December 2024, Springer Science + Business Media

    Carlo Alberto Artusi

  34. Behind the scenes: exploring neurological journal editors’ work habits, decisions, and potential sources of conflict of interest

    Article • Deutsche Zeitschrift für Nervenheilkunde, December 2024, Springer Science + Business Media

    Carlo Alberto Artusi

  35. Subthalamic and nigral stimulation for freezing of gait in Parkinson's disease: Randomized pilot trial

    Article • Journal of Parkinson’s Disease, November 2024, SAGE Publications

    Carlo Alberto Artusi

  36. Unraveling the stride: exploring the influence of neurogenic orthostatic hypotension on gait and balance in Parkinson’s disease

    Article • Clinical Autonomic Research, October 2024, Springer Science + Business Media

    Carlo Alberto Artusi

  37. NoMoFa as a new tool to evaluate the impact of deep brain stimulation on non-motor fluctuations: A new perspective

    Article • Parkinsonism & Related Disorders, September 2024, Elsevier

    Carlo Alberto Artusi

  38. Multidisciplinary care use in neurodegenerative complex diseases: The example of progressive supranuclear palsy and advanced Parkinson's disease in real-life

    Article • Parkinsonism & Related Disorders, August 2024, Elsevier

    Carlo Alberto Artusi

  39. Effects of Continuous Dopaminergic Stimulation on Parkinson’s Disease Gait: A Longitudinal Prospective Study with Levodopa Intestinal Gel Infusion

    Article • Journal of Parkinson’s Disease, June 2024, IOS Press

    Carlo Alberto Artusi

  40. Incidence and predictors of postural abnormalities in Parkinson’s disease: a PPMI cohort study

    Article • Deutsche Zeitschrift für Nervenheilkunde, May 2024, Springer Science + Business Media

    Carlo Alberto Artusi

  41. Neurological symptoms in adults with Gaucher disease: a systematic review

    Article • Deutsche Zeitschrift für Nervenheilkunde, May 2024, Springer Science + Business Media

    Carlo Alberto Artusi

  42. Botulinum Toxin for Axial Postural Abnormalities in Parkinson’s Disease: A Systematic Review

    Article • Toxins, May 2024, MDPI AG

    Carlo Alberto Artusi

  43. CACNA1A variant associated with generalized dystonia

    Article • Neurological Sciences, May 2024, Springer Science + Business Media

    Carlo Alberto Artusi

  44. Unveiling the Unpredictable in Parkinson’s Disease: Sensor-Based Monitoring of Dyskinesias and Freezing of Gait in Daily Life

    Article • Bioengineering, April 2024, MDPI AG

    Carlo Alberto Artusi

  45. Subthalamic and Nigral Stimulation for Freezing of Gait in Parkinson disease: randomized pilot trial

    Article • April 2024, Springer Science + Business Media

    Carlo Alberto Artusi

  46. Effects of dopaminergic therapy on sleep quality in fluctuating Parkinson’s disease patients

    Article • Deutsche Zeitschrift für Nervenheilkunde, April 2024, Springer Science + Business Media

    Carlo Alberto Artusi

  47. Treatment of axial postural abnormalities in parkinsonism disorders: A systematic review of pharmacological, rehabilitative and surgical interventions

    Article • Clinical Parkinsonism & Related Disorders, March 2024, Elsevier

    Dr Christian Geroin, Carlo Alberto Artusi

  48. Does sex influence the natural history of idiopathic adult-onset dystonia?

    Article • Journal of Neurology Neurosurgery & Psychiatry, March 2024, BMJ

    Carlo Alberto Artusi

  49. (Re)configuration of digital health records to optimize diagnosis and therapy

    Article • January 2024, Elsevier

    Carlo Alberto Artusi

  50. Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations

    Article • Neurological Sciences, November 2023, Springer Science + Business Media

    Carlo Alberto Artusi

  51. Are patients with GBA–Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort

    Article • Journal of Neurology Neurosurgery & Psychiatry, October 2023, BMJ

    Alessio Di Fonzo, Carlo Alberto Artusi

  52. Axial symptoms as main predictors of short-term subthalamic stimulation outcome in Parkinson's disease

    Article • Journal of the Neurological Sciences, October 2023, Elsevier

    Carlo Alberto Artusi

  53. Longitudinal Assessment of Botulinum Toxin Treatment for Lateral Trunk Flexion and Pisa Syndrome in Parkinson’s Disease: Real-life, Long-Term Study

    Article • Toxins, September 2023, MDPI AG

    Carlo Alberto Artusi

  54. Predictors and Pathophysiology of Axial Postural Abnormalities in Parkinsonism: A Scoping Review

    Article • Movement Disorders Clinical Practice, September 2023, Wiley

    Dr Christian Geroin, PhD Tamine Capato, Dr Mohammad Sami Alwardat, Carlo Alberto Artusi

  55. Pregnancy, fertile life factors, and associated clinical course in PRKN early-onset Parkinson’s disease

    Article • Neurological Sciences, September 2023, Springer Science + Business Media

    Carlo Alberto Artusi

  56. Filling the Gap in Assessing Pain in Dystonia

    Article • Movement Disorders, July 2023, Wiley

    Carlo Alberto Artusi

  57. Deep Brain Stimulation Outcomes in Parkinson's Disease Patients with Cognitive Impairment: Implications and Considerations

    Article • Movement Disorders Clinical Practice, June 2023, Wiley

    Carlo Alberto Artusi

  58. Axial Postural Abnormalities in Parkinsonism: Gaps in Predictors, Pathophysiology, and Management

    Article • Movement Disorders, April 2023, Wiley

    Dr Christian Geroin, PhD Tamine Capato, Dr Mohammad Sami Alwardat, Carlo Alberto Artusi

  59. Should we offer deep brain stimulation to Parkinson’s disease patients with GBA mutations?

    Article • Frontiers in Neurology, April 2023, Frontiers

    Carlo Alberto Artusi

  60. 15-Year Subthalamic Deep Brain Stimulation outcome in a Parkinson’s disease patient with Parkin gene mutation: a case report

    Article • Neurological Sciences, April 2023, Springer Science + Business Media

    Carlo Alberto Artusi

  61. The impact of dysphagia in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel

    Article • Parkinsonism & Related Disorders, April 2023, Elsevier

    Carlo Alberto Artusi

  62. Camera- and Viewpoint-Agnostic Evaluation of Axial Postural Abnormalities in People with Parkinson’s Disease through Augmented Human Pose Estimation

    Article • Sensors, March 2023, MDPI AG

    Dr Christian Geroin, Carlo Alberto Artusi

  63. Assessment of Axial Postural Abnormalities in Parkinsonism: Automatic Picture Analysis Software

    Article • Movement Disorders Clinical Practice, February 2023, Wiley

    Dr Christian Geroin, Carlo Alberto Artusi

  64. Gait and axial postural abnormalities correlations in Parkinson's disease: A multicenter quantitative study

    Article • Parkinsonism & Related Disorders, December 2022, Elsevier

    Carlo Alberto Artusi

  65. Visuospatial Deficits are associated with Pisa Syndrome and not Camptocormia in Parkinson's disease

    Article • Movement Disorders Clinical Practice, October 2022, Wiley

    Dr Christian Geroin, Prof. Cristoforo Comi, Carlo Alberto Artusi

  66. How resistant are levodopa‐resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease

    Article • European Journal of Neurology, October 2022, Wiley

    Carlo Alberto Artusi

  67. Efficacy of rituximab in anti‐myelin‐associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow‐up

    Article • European Journal of Neurology, September 2022, Wiley

    Carlo Alberto Artusi

  68. Burden of caregiving for cardiovascular dysautonomia in Parkinson’s disease

    Article • Clinical Autonomic Research, August 2022, Springer Science + Business Media

    Carlo Alberto Artusi

  69. Biomechanical assessment of botulinum toxin effects in Pisa syndrome disease

    Article • June 2022, Institute of Electrical & Electronics Engineers (IEEE)

    Carlo Alberto Artusi

  70. SARS-CoV-2 vaccination, Parkinson’s disease, and other movement disorders: case series and short literature review

    Article • Neurological Sciences, June 2022, Springer Science + Business Media

    Carlo Alberto Artusi

  71. Task force consensus on nosology and Cut‐Off values for axial postural abnormalities in parkinsonism

    Article • Movement Disorders Clinical Practice, April 2022, Wiley

    Dr Christian Geroin, PhD Tamine Capato, Carlo Alberto Artusi

  72. Postural abnormalities in Asian and Caucasian Parkinson's disease patients: A multicenter study

    Article • Parkinsonism & Related Disorders, April 2022, Elsevier

    Carlo Alberto Artusi

  73. Deep brain stimulation for atypical parkinsonism: A systematic review on efficacy and safety

    Article • Parkinsonism & Related Disorders, March 2022, Elsevier

    Carlo Alberto Artusi

  74. Time to onset and duration of botulinum toxin efficacy in movement disorders

    Article • Deutsche Zeitschrift für Nervenheilkunde, February 2022, Springer Science + Business Media

    Carlo Alberto Artusi

  75. Efficacy of safinamide as add-on therapy after subthalamic nucleus deep brain stimulation in Parkinson disease

    Article • Neurological Sciences, January 2022, Springer Science + Business Media

    Carlo Alberto Artusi

  76. Editorial: Advances in Functional Neurosurgery

    Article • Frontiers in Neurology, December 2021, Frontiers

    Carlo Alberto Artusi

  77. Standardized Biomechanical Investigation of Posture and Gait in Pisa Syndrome Disease

    Article • Symmetry, November 2021, MDPI AG

    Carlo Alberto Artusi

  78. Association between sleep disorders and cognitive dysfunctions in advanced Parkinson's disease

    Article • Journal of the Neurological Sciences, October 2021, Elsevier

    Carlo Alberto Artusi

  79. Botulinum toxin injection in longissimus and iliocostalis muscles for treating pisa syndrome: Short- and long-term effect

    Article • Journal of the Neurological Sciences, October 2021, Elsevier

    Carlo Alberto Artusi

  80. Cohort study of neurological comorbidities and COVID-19-related case fatality

    Article • Journal of the Neurological Sciences, October 2021, Elsevier

    Carlo Alberto Artusi

  81. Efficacy of amantadine in patients hospitalized with COVID-19: Study protocol of a randomized, double-blind, placebo-controlled trial

    Article • Journal of the Neurological Sciences, October 2021, Elsevier

    Carlo Alberto Artusi

  82. Freezing of gait in subthalamic deep brain stimulation for Parkinsons disease: A pilot study on safety and tolerability of variable versus low frequencies stimulation

    Article • Journal of the Neurological Sciences, October 2021, Elsevier

    Carlo Alberto Artusi

  83. The prognostic value of G325R GBA mutation on the long-term deep brain stimulation outcome in Parkinson's disease

    Article • Journal of the Neurological Sciences, October 2021, Elsevier

    Carlo Alberto Artusi

  84. Ventral tegmental area disconnection contributes two years early to correctly classify patients converted to Alzheimer’s disease: Implications for treatment

    Article • Journal of the Neurological Sciences, October 2021, Elsevier

    Carlo Alberto Artusi

  85. Early reversible leukoencephalopathy and unilateral sixth cranial nerve palsy in mild COVID-19 infection

    Article • Neurological Sciences, September 2021, Springer Science + Business Media

    Carlo Alberto Artusi

  86. G325R GBA mutation in Parkinson's disease: Disease course and long-term DBS outcome

    Article • Brain Stimulation, September 2021, Elsevier

    Carlo Alberto Artusi

  87. Neurological comorbidities and COVID-19-related case fatality: A cohort study

    Article • Journal of the Neurological Sciences, September 2021, Elsevier

    Carlo Alberto Artusi

  88. Ventral Tegmental Area Disconnection Contributes Two Years Early to Correctly Classify Patients Converted to Alzheimer’s Disease: Implications for Treatment

    Article • Journal of Alzheimer’s Disease, August 2021, IOS Press

    Carlo Alberto Artusi

  89. Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson’s disease

    Article • Deutsche Zeitschrift für Nervenheilkunde, July 2021, Springer Science + Business Media

    Carlo Alberto Artusi

  90. Effect of Deep Brain Stimulation Frequency on Gait Symmetry, Smoothness and Variability using IMU

    Article • June 2021, Institute of Electrical & Electronics Engineers (IEEE)

    Carlo Alberto Artusi

  91. Deep brain stimulation fine-tuning in Parkinson's disease: Short pulse width effect on speech

    Article • Parkinsonism & Related Disorders, June 2021, Elsevier

    Carlo Alberto Artusi

  92. Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic

    Article • Neurological Sciences, May 2021, Springer Science + Business Media

    Carlo Alberto Artusi

  93. Comment on: “Point of view: Wearable systems for at-home monitoring of motor complications in Parkinson's disease should deliver clinically actionable information”

    Article • Parkinsonism & Related Disorders, May 2021, Elsevier

    Carlo Alberto Artusi

  94. Deep brain stimulation outcomes in the malignant end of Parkinson's disease spectrum

    Article • Parkinsonism & Related Disorders, May 2021, Elsevier

    Carlo Alberto Artusi

  95. Motor and non-motor outcomes of subthalamic deep brain stimulation in a case of juvenile PARK-PINK1

    Article • Brain Stimulation, May 2021, Elsevier

    Carlo Alberto Artusi

  96. Focal seizures with impaired awareness as long-term neurological complication of COVID-19: a case report

    Article • Neurological Sciences, April 2021, Springer Science + Business Media

    Carlo Alberto Artusi

  97. COVID-19 and Parkinson’s Disease: What Do We Know So Far?

    Article • Journal of Parkinson’s Disease, April 2021, IOS Press

    Carlo Alberto Artusi

  98. Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials

    Article • Frontiers in Neurology, April 2021, Frontiers

    Carlo Alberto Artusi

  99. Safety and efficacy of tolcapone in Parkinson’s disease: systematic review

    Article • European Journal of Clinical Pharmacology, January 2021, Springer Science + Business Media

    Carlo Alberto Artusi

  100. Speech Impairment in Parkinson’s Disease: Acoustic Analysis of Unvoiced Consonants in Italian Native Speakers

    Article • IEEE Access, January 2021, Institute of Electrical & Electronics Engineers (IEEE)

    Carlo Alberto Artusi

  101. Digital work engagement among Italian neurologists

    Article • Therapeutic Advances in Chronic Disease, January 2021, SAGE Publications

    Carlo Alberto Artusi

  102. Low frequency subthalamic stimulation and event-related potentials in Parkinson disease

    Article • Parkinsonism & Related Disorders, January 2021, Elsevier

    Carlo Alberto Artusi

  103. Deep Brain Stimulation Selection Criteria for Parkinson’s Disease: Time to Go beyond CAPSIT-PD

    Article • Journal of Clinical Medicine, December 2020, MDPI AG

    Carlo Alberto Artusi

  104. COVID-19 in Parkinson's disease: Report on prevalence and outcome

    Article • Parkinsonism & Related Disorders, November 2020, Elsevier

    Carlo Alberto Artusi

  105. Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail

    Article • Neurological Sciences, October 2020, Springer Science + Business Media

    Carlo Alberto Artusi

  106. Levodopa/Carbidopa Intestinal Gel Long‐Term Outcome in Parkinson's Disease: Focus on Dyskinesia

    Article • Movement Disorders Clinical Practice, September 2020, Wiley

    Carlo Alberto Artusi, paola berchialla

  107. A new index to assess turning quality and postural stability in patients with Parkinson's disease

    Article • Biomedical Signal Processing and Control, September 2020, Elsevier

    Luigi Borzì, Carlo Alberto Artusi

  108. Neurological comorbidity and severity of COVID-19

    Article • Deutsche Zeitschrift für Nervenheilkunde, August 2020, Springer Science + Business Media

    Carlo Alberto Artusi

  109. Implementation of Mobile Health Technologies in Clinical Trials of Movement Disorders: Underutilized Potential

    Article • Neurotherapeutics, July 2020, Springer Science + Business Media

    Carlo Alberto Artusi

  110. Detection of Freezing of Gait in People with Parkinson’s Disease using Smartphones

    Article • July 2020, Institute of Electrical & Electronics Engineers (IEEE)

    Luigi Borzì, Carlo Alberto Artusi

  111. Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications

    Article • Deutsche Zeitschrift für Nervenheilkunde, June 2020, Springer Science + Business Media

    Carlo Alberto Artusi

  112. Smartphone-Based Evaluation of Postural Stability in Parkinson’s Disease

    Article • Electronics, June 2020, MDPI AG

    Carlo Alberto Artusi, Luigi Borzì

  113. Tuning Deep Brain Stimulation related depression by frequency modulation: a case report

    Article • Brain Stimulation, June 2020, Elsevier

    Carlo Alberto Artusi

  114. Onset of Covid-19 with impaired consciousness and ataxia: a case report

    Article • Deutsche Zeitschrift für Nervenheilkunde, May 2020, Springer Science + Business Media

    Carlo Alberto Artusi

  115. Should We Consider Deep Brain Stimulation Discontinuation in Late‐Stage Parkinson's Disease?

    Article • Movement Disorders, May 2020, Wiley

    Carlo Alberto Artusi, paola berchialla

  116. Changing the Side of Pisa Syndrome: A Case of Over‐Recovery with Botulinum Toxin

    Article • Movement Disorders Clinical Practice, April 2020, Wiley

    Carlo Alberto Artusi

  117. Does the Degree of Trunk Bending Predict Patient Disability, Motor Impairment, Falls, and Back Pain in Parkinson's Disease?

    Article • Frontiers in Neurology, March 2020, Frontiers

    Carlo Alberto Artusi

  118. Video analysis of long-term effects of levodopa-carbidopa intestinal gel on gait and posture in advanced Parkinson’s disease

    Article • Neurological Sciences, March 2020, Springer Science + Business Media

    Carlo Alberto Artusi

  119. Differential response to pallidal deep brain stimulation among monogenic dystonias: systematic review and meta-analysis

    Article • Journal of Neurology Neurosurgery & Psychiatry, February 2020, BMJ

    Carlo Alberto Artusi, MD Michael S Okun

  120. Smartphone-Based Estimation of Leg Agility in People With Parkinson's Disease

    Article • IEEE Open Journal of Engineering in Medicine and Biology, January 2020, Institute of Electrical & Electronics Engineers (IEEE)

    Carlo Alberto Artusi, Luigi Borzì

  121. Validity of the wall goniometer as a screening tool to detect postural abnormalities in Parkinson's disease

    Article • Parkinsonism & Related Disorders, December 2019, Elsevier

    Carlo Alberto Artusi

  122. Beyond 10 years of levodopa intestinal infusion experience: Analysis of mortality and its predictors

    Article • Parkinsonism & Related Disorders, October 2019, Elsevier

    Carlo Alberto Artusi

  123. Postural Abnormalities in Parkinson's Disease: An Epidemiological and Clinical Multicenter Study

    Article • Movement Disorders Clinical Practice, July 2019, Wiley

    Dr Christian Geroin, Carlo Alberto Artusi

  124. Home monitoring of motor fluctuations in Parkinson’s disease patients

    Article • Journal of Reliable Intelligent Environments, July 2019, Springer Science + Business Media

    Carlo Alberto Artusi, Luigi Borzì

  125. Telemedicine in Neurological Disorders: Opportunities and Challenges

    Article • Telemedicine and e-Health, July 2019, Mary Ann Liebert Inc

    Carlo Alberto Artusi

  126. Complex therapies for advanced Parkinson’s disease: what is the role of doctor-patient communication?

    Article • Neurological Sciences, June 2019, Springer Science + Business Media

    Carlo Alberto Artusi

  127. Levodopa-Induced Dyskinesias and Dyskinesias-Reduced-Self-Awareness in Parkinson’s Disease: A Neurocognitive Approach

    Article • June 2019, IntechOpen

    Carlo Alberto Artusi

  128. Pisa Syndrome in Parkinson's Disease Is Associated With Specific Cognitive Alterations

    Article • Frontiers in Neurology, May 2019, Frontiers

    Carlo Alberto Artusi

  129. Long‐term effect of levodopa‐carbidopa intestinal gel on axial signs in Parkinson’s disease

    Article • Acta Neurologica Scandinavica, May 2019, Wiley

    Carlo Alberto Artusi

  130. Botulinum toxin for Pisa syndrome: An MRI-, ultrasound- and electromyography-guided pilot study

    Article • Parkinsonism & Related Disorders, May 2019, Elsevier

    Carlo Alberto Artusi

  131. Effect of subthalamic deep brain stimulation on posture in Parkinson's disease: A blind computerized analysis

    Article • Parkinsonism & Related Disorders, May 2019, Elsevier

    Carlo Alberto Artusi

  132. Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study

    Article • Deutsche Zeitschrift für Nervenheilkunde, April 2019, Springer Science + Business Media

    Carlo Alberto Artusi

  133. Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease

    Article • JAMA Network Open, February 2019, American Medical Association (AMA)

    Carlo Alberto Artusi

  134. Levodopa‐Induced Neuropathy: A Systematic Review

    Article • Movement Disorders Clinical Practice, November 2018, Wiley

    Carlo Alberto Artusi

  135. Early diagnosis of progressive multifocal leucoencephalopathy: longitudinal lesion evolution

    Article • Journal of Neurology Neurosurgery & Psychiatry, November 2018, BMJ

    Carlo Alberto Artusi

  136. Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort study

    Article • Deutsche Zeitschrift für Nervenheilkunde, October 2018, Springer Science + Business Media

    Carlo Alberto Artusi

  137. Dopaminergic dose adjustment and negative affective symptoms after deep brain stimulation

    Article • Journal of the Neurological Sciences, July 2018, Elsevier

    Carlo Alberto Artusi

  138. Subthalamic deep brain stimulation and levodopa in Parkinson’s disease: a meta-analysis of combined effects

    Article • Deutsche Zeitschrift für Nervenheilkunde, June 2018, Springer Science + Business Media

    Carlo Alberto Artusi, MD Michael S Okun

  139. Deep brain stimulation in uncommon tremor disorders: indications, targets, and programming

    Article • Deutsche Zeitschrift für Nervenheilkunde, March 2018, Springer Science + Business Media

    Carlo Alberto Artusi

  140. Effects of intestinal Levodopa infusion on freezing of gait in Parkinson disease

    Article • Journal of the Neurological Sciences, February 2018, Elsevier

    Carlo Alberto Artusi

  141. Orthostatic hypotension in Parkinson disease: Impact on health care utilization

    Article • Parkinsonism & Related Disorders, February 2018, Elsevier

    Carlo Alberto Artusi

  142. Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases

    Article • Parkinsonism & Related Disorders, January 2018, Elsevier

    Carlo Alberto Artusi

  143. Subthalamic deep brain stimulation and trunk posture in Parkinson's disease

    Article • Acta Neurologica Scandinavica, December 2017, Wiley

    Maurizio Zibetti, Carlo Alberto Artusi

  144. To do or not to do? plasma exchange and timing of steroid administration in progressive multifocal leukoencephalopathy

    Article • Annals of Neurology, October 2017, Wiley

    Carlo Alberto Artusi

  145. Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis

    Article • Expert Opinion on Drug Safety, July 2017, Taylor & Francis

    Carlo Alberto Artusi

  146. Natalizumab in Multiple Sclerosis: Long-Term Management

    Article • International Journal of Molecular Sciences, April 2017, MDPI AG

    Carlo Alberto Artusi

  147. Prevalence and burden of dysautonomia in advanced Parkinson's disease

    Article • Movement Disorders, March 2017, Wiley

    Prof. Cristoforo Comi, Carlo Alberto Artusi

  148. Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab

    Article • Multiple Sclerosis Journal, February 2017, SAGE Publications

    Carlo Alberto Artusi

  149. The still under-investigated role of cognitive deficits in PML diagnosis

    Article • Multiple Sclerosis and Demyelinating Disorders, January 2017, Springer Science + Business Media

    Carlo Alberto Artusi

  150. Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry

    Article • PLOS One, December 2016, PLOS

    Carlo Alberto Artusi

  151. Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

    Article • Journal of Visualized Experiments, November 2016, MyJove Corporation

    Carlo Alberto Artusi

  152. Parkinsonism–hyperpyrexia syndrome and deep brain stimulation

    Article • Deutsche Zeitschrift für Nervenheilkunde, November 2015, Springer Science + Business Media

    Carlo Alberto Artusi

  153. Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia

    Article • Deutsche Zeitschrift für Nervenheilkunde, September 2015, Springer Science + Business Media

    Carlo Alberto Artusi

  154. Earlier versus later subthalamic deep brain stimulation in Parkinson's disease

    Article • Parkinsonism & Related Disorders, August 2015, Elsevier

    Carlo Alberto Artusi

  155. Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients

    Article • Deutsche Zeitschrift für Nervenheilkunde, June 2014, Springer Science + Business Media

    Carlo Alberto Artusi

  156. Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience

    Article • European Journal of Neurology, December 2013, Wiley

    Maurizio Zibetti, Carlo Alberto Artusi

  157. Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome?

    Article • Journal of Neurology Neurosurgery & Psychiatry, July 2013, BMJ

    Carlo Alberto Artusi

  158. Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients

    Article • Acta Neurologica Scandinavica, July 2013, Wiley

    Carlo Alberto Artusi

  159. 80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: Effects on involuntary movements

    Article • Parkinsonism & Related Disorders, April 2013, Elsevier

    Carlo Alberto Artusi

  160. Long-term duodenal levodopa infusion in Parkinson’s disease: a 3-year motor and cognitive follow-up study

    Article • Deutsche Zeitschrift für Nervenheilkunde, July 2012, Springer Science + Business Media

    Carlo Alberto Artusi

  161. Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients: A 15 months follow-up study

    Article • Brain Stimulation, July 2012, Elsevier

    Carlo Alberto Artusi

  162. Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset?

    Article • Journal of Neurology Neurosurgery & Psychiatry, December 2011, BMJ

    Carlo Alberto Artusi

  163. Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease

    Article • Movement Disorders, August 2011, Wiley

    Carlo Alberto Artusi

  164. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients

    Article • Brain, June 2011, Oxford University Press (OUP)

    Carlo Alberto Artusi